Tenaya Therapeutics, Inc.
TNYA
$0.73
-$0.01-1.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 393.33% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 393.33% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 393.33% | -- | |||
| SG&A Expenses | -0.75% | -8.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.47% | -2.33% | |||
| Operating Income | -4.16% | 3.42% | |||
| Income Before Tax | -125.16% | 4.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -125.16% | 4.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -125.16% | 4.48% | |||
| EBIT | -4.16% | 3.42% | |||
| EBITDA | -4.91% | 3.41% | |||
| EPS Basic | -124.30% | 22.90% | |||
| Normalized Basic EPS | -11.71% | 22.92% | |||
| EPS Diluted | -124.30% | 22.90% | |||
| Normalized Diluted EPS | -11.71% | 22.92% | |||
| Average Basic Shares Outstanding | 0.32% | 23.90% | |||
| Average Diluted Shares Outstanding | 0.32% | 23.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||